Xiamen, China

Liyan Xie

This inventor holds 2 USPTO granted patents. Top assignee: Xiamen LP Pharmaceutical Co., Ltd.. Active years: 2021-2024.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Liyan Xie: Innovator in Pharmaceutical Technologies

Introduction

Liyan Xie is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of two patents to his name, Xie is recognized for his advancements in treating oral health conditions.

Latest Patents

Liyan Xie's latest patents include an oral patch for treating mouth ulcers and a doxepin oral transmucosal film. The oral patch is designed for localized treatment of mouth ulcers and contains a combination of tetracaine and triamcinolone as active drugs. This bilayer structure features a drug layer with amorphous tetracaine hydrochloride and triamcinolone acetonide, along with a water-soluble backing layer. The formulation has shown improved efficacy compared to each individual drug. The doxepin oral transmucosal film is another innovative product that delivers doxepin through the buccal or sublingual mucosa. This film also has a bilayer structure, ensuring satisfactory bioavailability and improved palatability.

Career Highlights

Liyan Xie is currently associated with Xiamen LP Pharmaceutical Co., Ltd., where he continues to work on developing cutting-edge pharmaceutical solutions. His expertise in drug formulation and delivery systems has positioned him as a key player in the industry.

Collaborations

Xie collaborates with talented coworkers, including Rongbin Ling and Haijian Zhu, who contribute to his innovative projects and research endeavors.

Conclusion

Liyan Xie's work in pharmaceutical innovations demonstrates his commitment to improving healthcare solutions. His patents reflect a deep understanding of drug delivery mechanisms, which can significantly enhance patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…